Ligand Pharmaceuticals Inc Q4 2021 Earnings Call Transcript - Thomson StreetEvents

Ligand Pharmaceuticals Inc Q4 2021 Earnings Call Transcript

Ligand Pharmaceuticals Inc Q4 2021 Earnings Call Transcript - Thomson StreetEvents
Ligand Pharmaceuticals Inc Q4 2021 Earnings Call Transcript
Published Feb 17, 2022
Published Feb 17, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of LGND.OQ earnings conference call or presentation 17-Feb-22 9:30pm GMT

  
Report Type:

Transcript

Source:
Company:
Ligand Pharmaceuticals Inc
Ticker
LGND.OQ
Time
9:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jacob K. Johnson - Stephens Inc., Research Division - Analyst : Maybe, John, following up on your last answer to Matt's question. You talked -- Matt Foehr talked a little bit about the investment plan for OmniAb post spin. But maybe for legacy Ligand, can you talk about your interest in adding technologies to the platform and adding another leg to the stool at some point after the spin occurs?


Question: Jacob K. Johnson - Stephens Inc., Research Division - Analyst : Got it. And then a question for Matt Korenberg. I certainly understand there's moving pieces around expenses and so you're not guiding to it, but that means I'll still ask a question about it. Just in terms of the product gross margin line, any kind of directional indication about how we should think about that in '22 versus 2021, given the kind of Veklury probably mix shift of those revenues? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. FEBRUARY 17, 2022 / 9:30PM, LGND.OQ - Q4 2021 Ligand Pharmaceuticals Inc Earnings Call


Question: Jacob K. Johnson - Stephens Inc., Research Division - Analyst : Got it. That's helpful. And if I could just sneak in one more for Matt Foehr. Just lot of talk about OmniAb being spun out, but Icagen is part of that. Can you just remind me the kind of synergies between the OmniAb discovery assets and Icagen?

Table Of Contents

Ligand Pharmaceuticals Inc Investor and Analyst Day Transcript – 2022-12-13 – US$ 54.00 – Edited Transcript of LGND.OQ corporate analyst meeting</ 13-Dec-22 4:00pm GMT

Ligand Pharmaceuticals Inc Q3 2022 Earnings Call Transcript – 2022-11-07 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 7-Nov-22 9:30pm GMT

Ligand Pharmaceuticals Inc Q2 2022 Earnings Call Transcript – 2022-08-08 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 8-Aug-22 8:30pm GMT

Ligand Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2022-06-10 – US$ 54.00 – Edited Transcript of LGND.OQ shareholder or annual meeting 10-Jun-22 3:30pm GMT

Ligand Pharmaceuticals Inc Q1 2022 Earnings Call Transcript – 2022-05-04 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 4-May-22 8:30pm GMT

Ligand Pharmaceuticals Inc Q3 2021 Earnings Call Transcript – 2021-11-09 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 9-Nov-21 9:30pm GMT

Ligand Pharmaceuticals Inc Q2 2021 Earnings Call Transcript – 2021-07-29 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 29-Jul-21 8:30pm GMT

Ligand Pharmaceuticals Inc Annual Shareholders Meeting Transcript – 2021-06-04 – US$ 54.00 – Edited Transcript of LGND.OQ shareholder or annual meeting 4-Jun-21 3:30pm GMT

Ligand Pharmaceuticals Inc Q1 2021 Earnings Call Transcript – 2021-05-03 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 3-May-21 8:30pm GMT

Ligand Pharmaceuticals Inc Q4 2020 Earnings Call Transcript – 2021-02-03 – US$ 54.00 – Edited Transcript of LGND.OQ earnings conference call or presentation 3-Feb-21 1:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ligand Pharmaceuticals Inc Q4 2021 Earnings Call Transcript" Feb 17, 2022. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-Ligand-Pharmaceuticals-Inc-Earnings-Call-T15114654>
  
APA:
Thomson StreetEvents. (2022). Ligand Pharmaceuticals Inc Q4 2021 Earnings Call Transcript Feb 17, 2022. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-Ligand-Pharmaceuticals-Inc-Earnings-Call-T15114654>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.